Pharmaceuticals - Community Register

  

List of referrals for human medicinal products

Loratadine

Product name: Loratadine
Also marketed in the EU under the name(s): Alerdaune, Alerisa, Alertrin, Alerzid, Allerdrug, Allergofact, Allergostad, Allergy and Hayfever Relief Tablets, Alorin, Betalora, Biliranin, Bioglan generics laratadin, Bollinol, Chemolorat, Chemotadin, Civeran, Claritine, Claritine Reditabs, Clarityn, Clarityn Rapide, Clarityn-S, Clrityne, Crizin, Delor, Deloradin, Difmedol, Enatin, Evertine, Fadina, Fristamin, Geklimon, Hay-Rite, Hayrite, Helporigin, Histaclar, Histadin, Horestyl, Igir, Lantamed, Latoren, Licatidin, Lictyn, Lisino, Lisino S, Livotab, Loarev, Lobeta, Lora, Lora Basics, Lora Rhonol, Lora-Lich, Lora-Puren, Lora-Ratiopharm, Loraclar, Loraderm, Loradino, Loradis, Lorafile, Lorafluid, Loragalen, Loragamma, Loralerg, Loralerg, Loralic, Loramed, Loramix, Lorano, Lorapharm, Lorasan, Lorasol, Lorastad, Lorat, Loratabs, Loratad, Loratadin, Loratadina, Loratadindura, Loratadine, Loratadinum, Loratadura, Loratagam MA, Loratin, Loratyn, Loravis, Lorfuse, Loristine, Lóritín, Medallerg, Merck-Loratadine, Novacloxab, Optimin, Oratyn, Profenox, Ralinet, Ristotadin, Sanelor, Solamed, Tifitadin, Trilor, Tuulix, Utel, Velodan, Versal, Viaro, Vividrin, Zelmar, Zolargene
INN: Loratadine
Indication: Not available
Marketing Authorisation Holder: Not applicable

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2004 Referral EMEA/H/A-31/486 (2004)1768 of 28/04/2004